SYN-NIC-7 TRANSDERMAL ONEIRIC INDUCTION SYSTEM
nicotine transdermal patch, program use only. Synesthesia Health Division, a subsidiary of the Synesthesia Corporation.
document SYN-HLTH-INS-007 rev. K. read fully before lights out.
1. INDICATIONS AND USAGE
SYN-NIC-7 is indicated for the induction of high-recall, high- vividness REM sleep in Phase IV program subjects, in preparation for artifact recovery sessions. It is not indicated for smoking cessation. Subjects who begin smoking in order to qualify for the patch have misunderstood the program and will be reassigned.
2. DOSAGE AND ADMINISTRATION
Apply one system to clean, dry skin on the upper arm at lights out. Remove upon final waking. Site rotation per the table below. Titration is managed by your Program Coordinator and is not self-directed.
| Program week | System | Wear window | Reporting |
|---|---|---|---|
| 13 to 14 | SYN-NIC-7 / LOW | final REM cycle only | written report, morning |
| 15 to 18 | SYN-NIC-7 / STD | full night | written report, morning |
| 19 and on | SYN-NIC-7 / STD | full night, monitored | verbal debrief, on site |
The LOW system is a STD system cut in half. The Health Division is aware the manufacturer says not to cut the patch. See boxed warning regarding the manufacturer's general posture toward our work.
3. CONTRAINDICATIONS
- cardiovascular conditions, per standard nicotine labeling
- pregnancy or nursing
- concurrent restricted-tier cholinergics (see the index)
- a history of preferring the dream to the morning. screening question 44 addresses this. answer it honestly.
4. ADVERSE REACTIONS
Reported by more than five percent of Phase IV subjects:
- application site irritation
- false awakenings, sometimes serial
- waking with completed dream reports already written
- recognition of dream locations in subsequent corporate media releases
- homesickness for places that do not exist
Report adverse events to corporate@synesthesia.systems with subject line ADVERSE EVENT and your subject number. Do not describe the event in the subject line. We have asked before.
5. DRUG INTERACTIONS
SYN-NIC-7 is one entry in a 43-substance research index published in the corporate diary. Interactions within the index are managed at the protocol level. Consult the program page for the current phase structure, or the Oneironaut's Index for the full annotated catalog.
6. HOW SUPPLIED
Cartons of 14 systems, dispensed on site, two-week intervals. Systems are serialized and reconciled against your dream reports. Unreturned backing film is noted in your file.